Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth more ...
The drug, which was first approved in 2015, generated £1.6bn ($2.1bn) in revenue in 2023 for GSK, up 18% from the year before. It is predicted to see peak sales of $2.35bn in 2026, according to ...
M K Hamied has resigned from his position as Vice Chairman and Non-Executive Director of the pharma company, effective October 29, due to age and health reasons. The Board has appointed Adil ...
Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...
London: GSK plc has announced that the Japanese Ministry of Health ... She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma ...
But to Tucker, the very idea was “agonizing,” writes Attkisson in her new book, “Follow the Science: How Big Pharma Misleads, Obscures, and Prevails” (Harper, out Tuesday). Why?
The two small satellites were built by California-based Rocket Lab and UC Berkeley, which is leading the mission and has dubbed the satellites "Blue" and "Gold" after the school's traditional colors.
People living with HIV and people with potential exposure to HIV in China are expected to leverage more of GlaxoSmithKline's innovative research results for the prevention and treatment of the disease ...
The European Commission has authorized GSK's (LSE: GSK) Arexvy (respiratory syncytial virus ... All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data ...
Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers. SeeNews is your complete guide to the emerging ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the ...